Cyclotron for Molecular Imaging Program at USC

南加州大学分子成像项目回旋加速器

• 批准号: 7841076
• 负责人: Peter Stephen Conti
• 金额: $ 308.2万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2015-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7841076
• 关键词: Age; Area; Award; Cells; Chemistry; Cities; Clinical; Communities; Complement; Contract Services; Cyclotrons; Devices; Diagnostic; Discipline; Engineering; Funding; Future; Health Sciences; Housing; Human; Image; Institutes; Isotopes; Laboratory Animals; Magnetic Resonance Imaging; Medical; Medicine; Monitor; National Center for Research Resources; Nuclear; Occupations; Operating System; Optics; Pharmacology; Positron; Positron-Emission Tomography; Production; Productivity; Public Health; Radiation; Radio; Radioactivity; Radiochemistry; Radioisotopes; Radiopharmaceuticals; Request for Proposals; Research; Research Personnel; Safety; Security; Services; Site; Support System; System; Ultrasonography; United States National Institutes of Health; Work; instrument; miniaturize; molecular imaging; operation; pre-clinical; programs

DESCRIPTION (provided by applicant): During the last several years, a molecular Imaging Center has been established at USC with support over the last year from multiple awards from the NCRR and other NIH Institutes. Support from these agencies has been used to purchase several miniaturized versions of x-ray, optical, ultrasound and radio nuclear scanners for studies in small laboratory animals, as well as hot cells for radio synthesis of imaging agents for pre-clinical and clinical PET studies, and a human use 3T MRI. A central component of the molecular imaging effort has been the availability of a medical cyclotron for production of positron-emitting isotopes. Unfortunately, because of its age (nearly 20 years), the existing cyclotron can no longer service the needs of our ever-expanding network of investigators at USC and in the surrounding community. This proposal requests funding for a replacement cyclotron on the USC Health Sciences Campus. The requested device will be housed and operated in the Radiochemistry Facility of the Molecular Imaging Center, where it will complement other shared-use devices. The instrument chosen has numerous features conducive to efficient operation, including, ability to reliably produce PET radioisotopes in sufficient quantity and specific activity for use in basic radiochemistry research as well as for pre-clinical and investigative clinical imaging studies with current and future radiopharmaceuticals; is operator friendly; maximizes radiation safety of operators; is environmentally friendly with minimal radioactivity release and efficient use of utilities; has a robust, programmable and upgradable operating system with off-site monitoring and diagnostics capability; has minimal downtime; and comes with a strong service and parts support system. In addition, manufacturing of the primary systems components, assembly of device and service contract work are all provided for within the US, maximizing the impact of the purchase on US job creation and security. Investigators representing multiple disciplines including medicine, chemistry, pharmacology, and engineering, will use the requested cyclotron. Addition of the requested instrument will increase the productivity of assembled PHS-funded investigators from USC, Caltech and City of Hope who are working in these areas. The discoveries and advancements made by these investigators will ultimately have a direct positive impact on the local community as well as public health in general. PUBLIC HEALTH RELEVANCE: The Cyclotron and Radiochemistry Laboratory, along with the complementary molecular imaging resources available at USC, are indispensable to the growth of a broad spectrum of research programs at USC. Replacement of the aging cyclotron will strengthen both ongoing work in oncology, neurosciences, chemistry, pharmacy and genetic medicine by researchers, as well as greatly enhancing the ability of this Core to support new research. This enhancement will allow our investigators to continue to conduct cutting-edge research that will be reflected in our future grant submissions and publications.

描述（由申请人提供）：在过去的几年中，分子成像中心已在南加州大学成立，并在过去的一年中得到了NCRR和其他NIH研究所的多个奖项的支持。这些机构提供的支助已用于购买几种小型化的X射线、光学、超声和无线电核扫描仪，用于在小型实验室动物中进行研究，以及用于临床前和临床PET研究的成像剂无线电合成的热室，以及人类使用的3 T MRI。分子成像工作的一个核心组成部分是生产正电子发射同位素的医用回旋加速器的可用性。不幸的是，由于它的年龄（近20年），现有的回旋加速器不再能满足我们在南加州大学和周围社区不断扩大的调查网络的需求。该提案要求为南加州大学健康科学校区的回旋加速器更换提供资金。申请的器械将在分子成像中心的放射化学设施中存放和操作，在那里它将补充其他共享使用器械。所选仪器具有许多有利于有效操作的特点，包括能够可靠地生产足够数量和比活度的PET放射性同位素，用于基础放射化学研究以及使用当前和未来放射性药物进行临床前和调查性临床成像研究;操作员友好;最大限度地提高操作员的辐射安全性;环保，放射性释放最小，公用设施使用效率高;具有强大的、可编程的、可拆卸的操作系统，具有非现场监测和诊断能力;停机时间最短;并具有强大的服务和零件支持系统。此外，主要系统组件的制造、设备的组装和服务合同工作都在美国境内提供，从而最大限度地提高了采购对美国就业创造和安全的影响。 代表医学、化学、药理学和工程学等多个学科的研究者将使用所要求的回旋加速器。增加所要求的仪器将提高来自南加州大学、加州理工学院和希望之城的PHS资助的调查人员的工作效率。这些研究人员的发现和进步最终将对当地社区和公众健康产生直接的积极影响。 公共卫生关系：回旋加速器和放射化学实验室，沿着与南加州大学提供的互补分子成像资源，是南加州大学广泛的研究计划的发展不可或缺的。更换老化的回旋加速器将加强研究人员在肿瘤学、神经科学、化学、药学和遗传医学方面正在进行的工作，并大大提高该核心支持新研究的能力。这一增强将使我们的研究人员能够继续进行尖端研究，这将反映在我们未来的拨款申请和出版物中。